Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979


Appel, L. J., J. Charleston, P. R. Conlin, T. P. Erlinger, D. W. Harsha, E. R. Miller, T. J. Moore, and L. P. Svetkey. “The effect of race on circadian patterns of blood pressure: results from the dietary approaches to stop hypertension (DASH) feeding study.” Hypertension 36, no. 4 (October 1, 2000): 715–715.


Conlin, P. R., D. Chow, E. R. Miller, L. P. Svetkey, P. H. Lin, D. W. Harsha, T. J. Moore, F. M. Sacks, and L. J. Appel. “The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial..” Am J Hypertens 13, no. 9 (September 2000): 949–55.

Full Text

Klassen, P. S., and L. P. Svetkey. “Diagnosis and management of renovascular hypertension..” Cardiol Rev 8, no. 1 (January 2000): 17–29.


Sharma, L. P., E. J. Lewis, R. Rohde, R. P. Bain, P. K. Burrows, S. L. Edelstein, M. Pohl, et al. “Erratum: Captopril-induced reduction of serum levels of transforming growth factor-β1 correlates with long-term renoprotection in insulin- dependent diabetic patient's (American Journal of Kidney Diseases (1999) 34(818-823)).” American Journal of Kidney Diseases 35, no. 3 (2000).


Fielding, R. A., M. A. Violan, L. Svetkey, L. W. Abad, T. J. Manfredi, A. Cosmas, and J. Bean. “Effects of prior exercise on eccentric exercise-induced neutrophilia and enzyme release.” Medicine and Science in Sports and Exercise 32, no. 2 (2000): 359–64.


Getchell, W. S., L. P. Svetkey, L. J. Appel, T. J. Moore, G. A. Bray, and E. Obarzanek. “Summary of the Dietary Approaches to Stop Hypertension (DASH) Randomized Clinical Trial..” Curr Treat Options Cardiovasc Med 1, no. 4 (December 1999): 295–300.


Conlin, P. R., A. D. Bohannon, E. R. Miller, L. J. Appel, T. P. Erlinger, J. Hopkins, L. P. Svetkey, and T. J. Moore. “The DASH diet enhances the blood pressure response to losartan in African American hypertensive patients.” Circulation 100, no. 18 (November 2, 1999): 807–807.


Moore, T. J., W. M. Vollmer, L. J. Appel, F. M. Sacks, L. P. Svetkey, T. M. Vogt, P. R. Conlin, D. G. Simons-Morton, L. Carter-Edwards, and D. W. Harsha. “Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group..” Hypertension 34, no. 3 (September 1999): 472–77.


Plaisted, C. S., P. H. Lin, J. D. Ard, M. L. McClure, and L. P. Svetkey. “The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial..” J Am Diet Assoc 99, no. 8 Suppl (August 1999): S84–89.